Marshall Wace »

Karyopharm Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-09-30 $840k 129k 6.54
2025-06-30 $554k 129k 4.31
2025-03-31 $480k 129k 3.74

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms-a Common Stock (META)
Circle Internet Common Stock (CRCL)
Boston Scientifc Common Stock (BSX)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Adv Micro Device Common Stock (AMD)
Market Vectors S Equity Option Call Option (SMH)
Walmart Common Stock (WMT)
Johnson&johnson Common Stock (JNJ)
Cencora Common Stock (COR)

View all positions for Marshall Wace

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Adage Capital Partners GP
Vanguard Group
Susquehanna International
BlackRock
Affinity Asset Advisors
Catalio Capital Management
Avidity Partners Management
Marshall Wace
CAM Group Holding A/S
Geode Capital Management
Citadel Advisors
Group One Trading
Renaissance Technologies
UBS Group

View all funds holding Karyopharm Therapeutics